Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |
mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.34 | 0.1 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.1 |
mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.28 | 0.1 |